NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Macquarie University Hospital, North Ryde

Calvary Mater Hospital Newcastle, Waratah

Peter Maccallum Cancer Centre, Melbourne

Cabrini Hospital Malvern, Malvern

Linear Clinical Research, Nedlands

Laura & Isaac Perlmutter Cancer Center - NYU Langone Health, New York

Memorial Sloan Kettering Cancer Center, New York

Fox Chase Cancer Center, Philadelphia

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

NEXT Virginia, Fairfax

Virginia Oncology Associates, Norfolk

Carolina BioOncology Institute, Huntersville

H. Lee Moffitt Cancer Center, Tampa

Sarah Cannon Research Institute - Tennessee Oncology, Nashville

Karmanos Cancer Institute, Detroit

Mary Crowley Cancer Research, Dallas

Texas Oncology - Fort Worth Cancer Center, Fort Worth

Rocky Mountain Cancer Centers, LLP, Aurora

Rocky Mountain Cancer Centers, LLP, Lone Tree

The University of Arizona Cancer Center, Tucson

Ellison Institute of Technology, Los Angeles

Massachusetts General Hospital, Boston